LL-37 Made in USA — Third-Party Verified

Overview of LL-37 in Preclinical and In Vitro Research

LL-37 is the sole active C-terminal cleavage product of the human cathelicidin antimicrobial protein CAP18 (hCAP18). Consisting of a 37-residue sequence starting with two leucine residues (LL-37: Leu-Leu-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser), this peptide is a principal component of the innate immune defense architecture in mammals.

In academic and industrial laboratory settings, researchers investigate LL-37 made in usa to elucidate mechanisms surrounding pathogen membrane lysis, chemokine receptor recruitment, neutralization of lipopolysaccharides (LPS), and tissue remodeling signaling cascades. Because of its amphipathic alpha-helical structure, LL-37 serves as a benchmark compound in bio-membrane interaction models and host defense peptide kinetics across various research peptides domains.

To ensure reproducible experimental outcomes in sensitive cell culture and biophysical assays, researchers require peptides manufactured with rigorous controls. Variations in sequence fidelity, residual counter-ions, or trace endotoxins can significantly skew research outcomes. PX1 Research supplies domestically synthesized LL-37 designed specifically to eliminate variables associated with variable-quality international manufacturing.

Molecular Structure, Amphipathicity, and Conformational Dynamics

The molecular architecture of LL-37 is characterized by a high net positive charge (+6 at physiological pH) attributable to its abundant arginine and lysine residues. Structurally, the peptide transitions from an unstructured random coil in aqueous, low-ionic-strength solutions into a well-defined amphipathic alpha-helix upon exposure to hydrophobic environments, lipid bilayers, or physiological salt concentrations.

Preclinical biophysical studies indicate that this structural plasticity allows LL-37 to insert into negatively charged lipid bilayers. The positively charged hydrophilic face interacts with anionic phospholipid headgroups, while the hydrophobic face penetrates the core of the membrane. In vitro spectroscopic assays (such as circular dichroism and nuclear magnetic resonance) show that the alpha-helical content directly correlates with its membrane-binding affinity and biological activity.

Understanding these structural dynamics requires analytical grade materials free of peptide truncations or modified side-chain adducts. At PX1 Research, our domestic synthesis workflows ensure complete peptide chain elongation and precise folding kinetics, giving investigators confidence in their structural biology and biophysical data.

Primary Mechanisms of Action: Membrane Interaction and Receptor Signaling

Preclinical models have identified two distinct primary mechanisms by which LL-37 interacts with biological systems: direct physical membrane disruption and receptor-mediated cell signaling.

In direct membrane interaction models, in vitro studies demonstrate that LL-37 functions via a 'toroidal pore' or 'carpet-like' mechanism. Upon reaching a threshold surface concentration on negatively charged microbial membranes, the peptide aligns parallel to the lipid surface, driving local curvature strain that leads to transient pore formation, membrane depolarization, and eventual osmotic disruption.

Beyond structural membrane interactions, preclinical research highlights LL-37 as a potent signaling ligand. In vitro assays demonstrate that LL-37 acts as an agonist for Formyl Peptide Receptor-Like 1 (FPRL1/FPR2), inducing intracellular calcium mobilization and directed chemotaxis of neutrophils, monocytes, and T-lymphocytes. Additionally, LL-37 interacts with Purinergic Receptor P2X7 and Epidermal Growth Factor Receptor (EGFR) pathways, driving research into epithelial cell migration, angiogenesis, and inflammatory signaling cascades.

The Strategic Importance of Domestic USA Synthesis

Sourcing laboratory reagents that exhibit chemical consistency across multiple batch lots is a persistent challenge in life science research. When procurement relies on foreign supply chains, laboratories frequently encounter batch-to-batch variation, unannounced manufacturing changes, high racemization rates, and degraded chemical stability resulting from prolonged transit times.

By choosing high-purity LL-37 made in usa, research institutions gain direct oversight of the manufacturing lineage. PX1 Research utilizes modern solid-phase peptide synthesis (SPPS) protocols within state-of-the-art, GMP-compliant facilities based in the United States. Domestic manufacturing guarantees rigid climate control, immediate cold-chain management, and rapid dispatch from our California and Arizona fulfillment hubs.

Elimination of international shipping delays ensures that lyophilized peptides do not undergo temperature spikes that compromise structural integrity. For institutional labs operating under strict timeline and grant compliance frameworks, sourcing domestically synthesized compounds provides supply chain reliability and transparent analytical verification.

Comprehensive Quality Control: HPLC, Mass Spectrometry, and Endotoxin Analysis

To guarantee that every vial meets exacting scientific parameters, PX1 Research subjects all production lots to exhaustive analytical verification performed by an independent, ISO 17025 accredited testing facility.

Every batch of LL-37 undergoes High-Performance Liquid Chromatography (HPLC) to establish chemical purity profiles. Our baseline standards mandate a minimum of 98% purity, ensuring the complete absence of truncated sequences, deletion sequences, or unreacted reagents. Concurrently, Liquid Chromatography-Mass Spectrometry (LC-MS) is conducted to verify the precise molecular mass (4493.3 Da) and confirm sequence identity.

Because LL-37 is frequently employed in immunological and cell culture assays where trace bacterial contaminants can invalidate results, endotoxin testing is paramount. Every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to verify endotoxin levels well below strict regulatory research thresholds (<0.01 EU/µg). Researchers can review lot-specific Certificates of Analysis (COAs) directly prior to incorporating compounds into active experimental protocols via our peptide purity testing hub.

Comparative Analysis: LL-37 in the Context of Host Defense and Immune Modulation Peptides

When designing preclinical experiments targeting inflammatory pathways or cellular defense networks, investigators frequently evaluate LL-37 alongside other specialized peptides. A comparative assessment of primary mechanisms helps clarify the specific experimental utility of each agent.

While LL-37 functions as a broad-spectrum, amphipathic host defense peptide utilizing both membrane perturbation and FPR2 receptor activation, other signaling peptides target distinct structural or physiological pathways. For instance, KPV is a tripeptide derived from alpha-MSH evaluated primarily for its focused anti-inflammatory signaling via nuclear factor-kappa B (NF-κB) suppression rather than direct membrane disruption. Similarly, Thymosin Alpha-1 operates as an immune-modulating peptide that regulates T-cell differentiation and toll-like receptor signaling without exhibiting amphipathic lytic activity. In tissue repair and extracellular matrix remodeling assays, investigators often cross-compare LL-37 with BPC-157, which focuses predominantly on angiogenic upregulation and focal adhesion kinase pathways. Exploring these distinct profiles within our antimicrobial peptides directory allows researchers to select the precise molecular tool required for their specific pathway analysis.

In Vitro Assay Applications and Research Protocols

In laboratory research settings, LL-37 is utilized across a broad range of experimental protocols designed to analyze biological responses at the cellular and sub-cellular level.

In vitro studies commonly utilize LL-37 in liposome leakage assays and planar lipid bilayer experiments to quantify the kinetics of pore formation and voltage-dependent ion conductance. In immunological research, primary cell cultures and immortalized cell lines (such as THP-1 monocytes or HaCaT keratinocytes) are exposed to controlled concentrations of LL-37 to quantify downstream cytokine expression (including IL-8, TNF-alpha, and IL-1 beta) via ELISA or quantitative RT-PCR.

Additionally, LL-37 is frequently evaluated in scratch-wound cell migration assays to model epithelial restitution. In vitro data indicate that LL-37-induced cell migration depends on transactivation of the EGFR pathway and downstream activation of extracellular signal-regulated kinases (ERK1/2). Researchers conducting these assays rely on the consistent chemical properties of PX1 Research compounds to ensure that observed responses stem solely from specific peptide-receptor interactions.

Solubility, Reconstitution, and Laboratory Storage Protocols

Proper reconstitution and storage procedures are essential to maintain the structural stability and bioactivity of lyophilized LL-37 in laboratory environments.

Lyophilized LL-37 should be stored at -20°C or -80°C in a manual defrost freezer away from light. Prior to reconstitution, vials should be allowed to equilibrate to room temperature inside a desiccator to prevent atmospheric moisture condensation on the lyophilized cake.

For reconstitution, sterile bacteriostatic water, sterile deionized water, or low-salt phosphate-buffered saline (PBS, pH 7.4) is recommended. Because LL-37 can bind hydrophobic glass and plastic surfaces at low concentrations, inclusion of a carrier protein such as 0.1% Bovine Serum Albumin (BSA) or utilization of low-binding polypropylene tubes is advised when preparing dilute working aliquots. Reconstituted stock solutions should be aliquoted into single-use volumes and stored at -80°C to prevent degradation from repeated freeze-thaw cycles. Detailed reconstitution guidelines are available in our lyophilized storage guidelines.

Institutional Procurement and Wholesale Research Supplies

PX1 Research supports university laboratories, contract research organizations (CROs), and biotechnology firms with reliable procurement options tailored to ongoing project requirements.

Whether procuring individual vials for preliminary feasibility studies or securing multi-gram quantities for large-scale preclinical screening programs, institutional buyers benefit from verified batch uniformity and full chain-of-custody documentation. We offer dedicated account management and scaled pricing structures for high-volume orders through our wholesale lab account portal.

Orders placed Monday through Friday before our daily cut-off time ship same-day from our California or Arizona facilities under temperature-controlled packaging standards. By combining domestic synthesis, stringent ISO 17025 verification, and rapid logistics, PX1 Research stands as a premier supply partner for advanced peptide research.